Progressive MS: 22 new research projects funded
Published date: 12 Sep 2014 at 8:02AM
The MS Society has joined MS charities around the world in funding 22 research projects aimed at developing successful treatments for people with progressive MS.
This is our most ambitious progressive MS research initiative to date. We’re working with MS charities in the USA, Canada, Italy, Australia and the MS International Federation, with additional support from MS charities in Denmark and Spain, to collectively form the ‘Progressive MS Alliance’, and make funding new research a reality.
More than 22 million Euros (about £17.5m) has been made available to fund the Alliance over the next five years.
Bigger projects, quicker answers
The global funding will speed up research into the condition, as scientists will be able to share knowledge and expertise, and will avoid duplicating work.
Working with other charities means we’re able to spend more on research – funding bigger, more expensive projects, and a greater number of projects, compared to if we were working alone.
The Alliance has agreed four priority areas, on which research will be focused:
- Better understand progression so we can identify new treatments that can help
- Design shorter, faster trials to reduce the time taken for new treatments to be approved
- Conduct trials to test potential drugs and treatments
- Develop and evaluate new therapies to manage symptoms
UK based projects
Of the 22 projects, four are based in the UK and will focus on topics ranging from understanding the genetics and cellular biology of MS, to improving balance and developing better ways to measure and record symptoms.
The other projects are based in USA, Canada, Sweden, the Netherlands, Denmark, Italy, Australia and Belgium.
Michelle Mitchell, Chief Executive of the MS Society, said: “We know that people with MS desperately want treatments that can slow, stop or reverse the effects of MS progression – and by working with MS charities across the world, we hope to achieve this.
She continued: “This collaboration is ignoring international borders, we’re simply funding the best science in the world – such is the need to urgently get answers.”
Support, and read more
We know that people with MS desperately want treatments that can slow, stop or reverse the effects of MS progression – and by working with MS charities across the world, we hope to achieve this.Michelle Mitchell, Chief Executive, MS Society